Analyze Diet
American journal of veterinary research2005; 66(12); 2065-2072; doi: 10.2460/ajvr.2005.66.2065

Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.

Abstract: To determine whether a deficiency in systemic or local (pars intermedia) antioxidant capacity is associated with pituitary pars intermedia oxidative stress and pituitary pars intermedia dysfunction (PPID) in horses. Methods: Blood samples from 20 horses with PPID and 20 healthy client-owned horses, archived paraffin-embedded adrenal gland and substantia nigra tissues from 20 horses, and pituitary gland tissue from 16 horses. Methods: Total glutathione, superoxide dismutase, and glutathione peroxidase activities were determined in RBCs. Accumulation of a systemic marker of oxidative stress (3-nitrotyrosine) was assessed in plasma and formalin-fixed, paraffin-embedded adrenal gland and substantia nigra tissues. Local antioxidants (total and manganese superoxide dismutase, glutathione peroxidase, and total glutathione) were measured in pars intermedia tissues. Results: No significant differences existed in systemic antioxidant enzyme activity or accumulation of 3-nitrotyrosine between horses with PPID and control horses. In pituitary gland tissues, glutathione peroxidase activity was increased in horses with oxidative stress, whereas total glutathione concentration and superoxide dismutase activity remained unchanged. There was an age-associated decrease in manganese superoxide dismutase activity in the pars intermedia. Conclusions: There was no evidence of systemic accumulation of oxidative stress markers or deficiencies in antioxidant capacity in horses with PPID, suggesting that these are unlikely to be major predisposing factors in the development of PPID. Manganese superoxide dismutase activity in the pars intermedia decreased significantly with increasing age. Role of an age-associated decrease in antioxidant capacity for the pars intermedia in the development of PPID in horses warrants further investigation.
Publication Date: 2005-12-29 PubMed ID: 16379648DOI: 10.2460/ajvr.2005.66.2065Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates whether a deficiency in the body’s antioxidant capacity is linked with the oxidative stress and dysfunction of the pituitary pars intermedia, specifically in the instance of horses suffering from pituitary pars intermedia dysfunction (PPID). The findings show no significant evidence of systemic accumulation of oxidative stress or antioxidant deficiencies contributing to the development of PPID. However, it was observed that a particular antioxidant enzyme, Manganese superoxide dismutase, decreased with age in the pituitary pars intermedia.

Research Subject and Methodology

  • The focus of the study was to determine if there’s a correlation between a deficiency in the antioxidant capacity of the body or the pituitary pars intermedia (a part of the pituitary gland), and the development of pituitary pars intermedia dysfunction (PPID) in horses.
  • A sample set of 40 horses were involved in the research, 20 with diagnosed PPID and 20 healthy ones. The study also included an analysis of stored adrenal gland and substantia nigra tissues from 20 horses, along with pituitary gland tissue from 16 horses.
  • To evaluate their antioxidant capacity, the researchers assessed total glutathione, superoxide dismutase, and glutathione peroxidase activities in their red blood cells. An additional systemic marker of oxidative stress (3-nitrotyrosine) was examined in horses’ blood plasma, and adrenal gland and substantia nigra tissues.

Results of the Study

  • The results showed no significant disparities in systemic antioxidant enzyme activity or accumulation of 3-nitrotyrosine between horses with PPID and control horses.
  • In the pituitary gland tissues, glutathione peroxidase activity was elevated in horses with oxidative stress, but there was no change in total glutathione concentration and superoxide dismutase activity.
  • An age-related decrease was observed in the activity of an antioxidant enzyme, Manganese superoxide dismutase, in the pars intermedia.

Conclusions and Further Studies

  • The data suggests there’s no significant evidence that points towards systemic oxidative stress accumulation or antioxidant capacity deficiencies playing a pivotal role in the onset of PPID in horses.
  • Nonetheless, it was discovered that Manganese superoxide dismutase activity in the pars intermedia significantly dropped with age. Consequently, further research is recommended to better understand the implications of this observation in relation to the development of PPID in horses.

Cite This Article

APA
McFarlane D, Cribb AE. (2005). Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses. Am J Vet Res, 66(12), 2065-2072. https://doi.org/10.2460/ajvr.2005.66.2065

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 66
Issue: 12
Pages: 2065-2072

Researcher Affiliations

McFarlane, Dianne
  • Department of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE C1A 4P3, Canada.
Cribb, Alastair E

    MeSH Terms

    • Age Factors
    • Animals
    • Antioxidants / metabolism
    • Erythrocytes / metabolism
    • Glutathione / metabolism
    • Glutathione Peroxidase / metabolism
    • Horse Diseases / metabolism
    • Horses
    • Oxidative Stress / physiology
    • Pituitary Diseases / metabolism
    • Pituitary Diseases / veterinary
    • Pituitary Gland / metabolism
    • Superoxide Dismutase / metabolism
    • Tyrosine / analogs & derivatives
    • Tyrosine / blood
    • alpha-MSH / metabolism

    Citations

    This article has been cited 9 times.
    1. Kirkwood NC, Hughes KJ, Stewart AJ. Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID). Vet Sci 2022 Oct 17;9(10).
      doi: 10.3390/vetsci9100572pubmed: 36288186google scholar: lookup
    2. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses. Vet Sci 2022 Oct 10;9(10).
      doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
    3. Fortin JS, Hetak AA, Duggan KE, Burglass CM, Penticoff HB, Schott HC 2nd. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy. Sci Rep 2021 Aug 6;11(1):16036.
      doi: 10.1038/s41598-021-95396-7pubmed: 34362943google scholar: lookup
    4. Tatum RC, McGowan CM, Dean RS, Ireland JL. Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership. PLoS One 2021;16(1):e0244784.
      doi: 10.1371/journal.pone.0244784pubmed: 33395695google scholar: lookup
    5. Fortin JS, Benskey MJ, Lookingland KJ, Patterson JS, Howey EB, Goudreau JL, Schott HC 2nd. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction. BMC Vet Res 2020 Sep 25;16(1):356.
      doi: 10.1186/s12917-020-02565-3pubmed: 32977825google scholar: lookup
    6. Żak A, Siwińska N, Chełmecka E, Bażanów B, Romuk E, Adams A, Niedźwiedź A, Stygar D. Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses. Antioxidants (Basel) 2020 May 21;9(5).
      doi: 10.3390/antiox9050444pubmed: 32455574google scholar: lookup
    7. Spelta CW. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management. Vet Med (Auckl) 2015;6:293-300.
      doi: 10.2147/VMRR.S74191pubmed: 30101114google scholar: lookup
    8. Banse HE, Frank N, Kwong GP, McFarlane D. Relationship of oxidative stress in skeletal muscle with obesity and obesity-associated hyperinsulinemia in horses. Can J Vet Res 2015 Oct;79(4):329-38.
      pubmed: 26424915
    9. Vaughn SA, Lemons MB, Hart KA. The Effect of Season and Breed on Hypothalamic-Pituitary-Adrenal Axis Hormones, Metabolic Hormones, and Oxidative Markers in Ponies and Horses. J Vet Intern Med 2025 Mar-Apr;39(2):e70047.
      doi: 10.1111/jvim.70047pubmed: 40048369google scholar: lookup